advertisement

Advocate Good Shepherd Hospital Receives Outstanding Achievement Award from American College of Surgeons Commission on Cancer

Advocate Good Shepherd Hospital's Cancer Program, has received the Outstanding Achievement Award from the American College of Surgeons (ACS) Commission on Cancer. Good Shepherd is one of five hospitals in the state of Illinois to receive this recognition.

"Earning this national distinction is clear evidence that our remarkable cancer team offers our community the finest cancer treatment," says Karen Lambert, President Advocate Good Shepherd Hospital.

"We are proud to be part of such a talented team that excels in all key cancer program standards and offers patients groundbreaking cancer treatment innovation, technology and research," said Michael Soble, MD Cancer Committee Chairman at Advocate Good Shepherd Hospital.

Established in 2004, the ACS Commission on Cancer Outstanding Achievement Award is designed to recognize cancer programs that strive for excellence in providing quality care to cancer patients. A facility or program can earn the award following an on-site evaluation by a physician surveyor during which the program demonstrates compliance with seven standards of excellence established by the Commission. The standards are: cancer committee leadership, cancer data management, clinical management, research, community outreach and quality improvement efforts.

Award recipients represent community-based facilities, teaching hospitals/academic medical centers, NCI-designated Comprehensive Cancer Centers, VA hospitals and network cancer programs as well as newly accredited programs and programs currently accredited by the Commission on Cancer.

Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.